Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03747068 Completed - Ulcerative Colitis Clinical Trials

The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.

Start date: October 9, 2009
Phase:
Study type: Observational

BACKGROUND: Previous studies of short-term surgical outcomes after preoperative exposure to anti-TNF therapy in ulcerative colitis (UC) patients who have undergone IPAA have been conflicting. We sought to determine whether preoperative exposure to anti-TNF therapy affects histological measures of fibrosis in the colorectum, which may be a potential factor in adverse anastomosis complications following IPAA surgery. METHODS: Individuals who received infliximab as maintenance therapy and who received their last dose within 180 days of the first stage of IPAA were selected. The control group comprised UC patients who were not exposed to anti-TNF therapy, matched by age, sex, BMI, disease duration, albumin levels, and post-operative leak outcome. Hematoxylin and eosin- (H&E) and trichrome-stained slides from the most distal, well-oriented, full-thickness section of colorectum from each patient's total colectomy specimen were evaluated. Blinded assessment of the degree of fibrosis in the lamina propria, the submucosa, the submucosa immediately adjacent to the muscularis propria, and the subserosa was performed by a single observer using a semi-quantitative pictorial scale.

NCT ID: NCT03746873 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Increase Level of Physical Activity and Decrease Use of Health Care for People With COPD

COPD
Start date: November 15, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effects of the COPD Web (KOLwebben), an interactive web-based tool directed towards people with chronic obstructive pulmonary disease (COPD). The COPD Web include tools that improve health literacy with a specific focus on 1) increased physical activity and 2) use of appropriate self-management strategies. This randomized clinical trial aims to generate evidence on the effect and usability of the COPD Web in a properly powered cohort of patients in primary care context.

NCT ID: NCT03746860 Completed - Clinical trials for Allergic Rhinitis Due to House Dust Mite

N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France

CARIOCA
Start date: May 9, 2018
Phase:
Study type: Observational

Non-interventional study to investigate the safety and tolerability of allergy immunotherapy ACARIZAX® 12 SQ-HDM in real-life clinical practice in adults patients (>18 years) with house dust mite allergy over a period of 12 months.

NCT ID: NCT03746717 Completed - Clinical trials for Metastatic Bone Disease of the Proximal Femur

Occlusive Skin Closure May Reduce Wound Drainage After Tumor Hip Arthroplasty

Start date: January 15, 2017
Phase: N/A
Study type: Interventional

Study Type: Investigator initiated, non-significant risk Study Objective(s): To establish the effect of occlusive wound closure with the DERMABONDTM PRINEO skin closure system, compared to routine wound closure with skin staples, on post-operative wound discharge (PWD) after tumor arthroplasty of the hip Study Population: Patients with secondary tumors of bone, undergoing tumor resection and primary endoprosthetic reconstruction involving the hip joint Inclusion Criteria: - Bone resection and endoprosthetic reconstruction for metastatic bone lesions involving the proximal femur or acetabulum - Imminent, or de-facto pathologic fractures of proximal femur and/or acetabulum, requiring endoprosthetic reconstruction (with or without bone resection) involving the hip joint Exclusion Criteria: - Minors - Pregnant and breast-feeding women - Skin defects and wound conditions not amenable to primary wound closure and other DERMABOND PRINEO contraindications - Underlying infection - Total femur replacements - Implant revision procedures Structure: Open 2-arm prospective randomized controlled trial. Duration of Study: 18 -24 months Multi-center: No Masking/Blinding: No Method of Subject Assignment: Block Randomization (10 in each block) Concurrent Control: Active - wound closure with skin staples Estimated Total Sample Size: 70 subjects will be enrolled in this study Statistical Rationale Provided: Yes Statistical Methods: Student t test for unpaired data Study Endpoints: - Time to dry wound status (in post-operative days) - Duration of antibiotic use (in post-operative days) - Length of hospital stay (in post-operative days)

NCT ID: NCT03746639 Completed - Low Back Pain Clinical Trials

Therapeutic Ultrasound on Renal Function

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

This study evaluates whether therapeutic ultrasound (TUS) treatment applied to lumbar region with chronic low back pain affect renal function.

NCT ID: NCT03746600 Completed - HIV/AIDS Clinical Trials

Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS

TRAC
Start date: June 5, 2019
Phase: N/A
Study type: Interventional

While advances in medication have led to greatly improved outcomes for people living with HIV/AIDS, less than one-third of all people living with the disease are adherent enough to their medication to achieve viral suppression. Alcohol consumption has been shown to have a significant effect on HIV medication adherence, so the proposed research will aim to reduce alcohol use among people living with HIV/AIDS through a technology-driven intervention. This eight-session intervention will be delivered using a combination of videoconferencing, smart phones, and Bluetooth-enabled breathalyzers for monitoring of alcohol consumption, with an overall goal of reducing alcohol use, mitigating adherence issues, and achieving optimal prevention and treatment responses for people living with HIV/AIDS.

NCT ID: NCT03746483 Completed - Clinical trials for Cystic Fibrosis (CF)

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

OPTION
Start date: January 10, 2019
Phase: Phase 2
Study type: Interventional

The primary objectives of this study are to assess the safety and efficacy of MS1819-SD vs porcine pancreatic enzyme replacement therapy (PERT) in patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF).

NCT ID: NCT03746418 Completed - Clinical trials for Lumbar Fixation Surgery

Effect of Addition of Dexmedetomidine During Ultrasound Guided Bilateral Single Shot Erector Spinae Plane Block in Patients Undergoing Posterior Lumbar Interbody Fusion Under General Anesthesia

Start date: January 1, 2016
Phase: Early Phase 1
Study type: Interventional

Posterior lumbar interbody fusion (PLIF) is the management of choice in double level lumbar (L) spondylolisthesis (L3-L5) after ineffective conservative treatment. We evaluated bilateral ultrasound (US)-guided single shot erector spinae plane (ESP) block at the level of lumbar 3 (L3) vertebra with or without dexmedetomidine (Dex).

NCT ID: NCT03746392 Completed - Dementia Clinical Trials

Project to Improve Communication About Serious Illness - Pilot Study

PICSI-P
Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This two-year pilot study will test whether a one-page "Jumpstart Form" will affect goals-of-care discussions in the hospital. This form will be provided to clinicians and will include patient-specific information about preferences for goals-of-care communication and for care, as well as tips to improve this communication. Jumpstart forms will also be provided to patients or, if they are unable to communicate, their surrogates/family members. The information on the form will be obtained from questionnaires. The form is tailored to help patients and surrogates talk with clinicians about goals of care. This study is based on a successful application of Jumpstart Form in the outpatient clinic setting.

NCT ID: NCT03746301 Completed - Clinical trials for Non-valvular Atrial Fibrillation (NVAF)

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

XARENAL
Start date: December 3, 2018
Phase:
Study type: Observational

The purpose of the study is to evaluate the safety and effectiveness of Xarelto in renally impaired patients with NVAF under routine practice conditions. The information collected in the XARENAL study will help to understand how renally impared patients with NVAF are treated in the real-world setting and what the outcome for the patients is under those conditions.